Frequently Asked Questions

Q: What does FDA approval of CEPROTIN [Protein C Concentrate (Human)] mean for me?

FDA approval means that the U.S. Food and Drug Administration has completed its evaluation of safety and efficacy data submitted by Shire plc. and has licensed CEPROTIN therapy for the U.S.

Q: What are Shire’s long-term plans for CEPROTIN therapy?

Shire is committed to meeting the needs of patients. With CEPROTIN therapy, we will work closely with all patients with the goal of helping to ensure that they have continued access to this therapy.

Q: Is there a patient assistance program?

As part of our ongoing commitment to the patient community, Shire is working with third-party partners to assist patients, family members and physicians by conducting insurance verification, pursuing prior authorization and identifying the best coverage options for Protein C.

Q: How will I get CEPROTIN therapy when I need it?

Your physician will assist you in obtaining CEPROTIN therapy.

Q: Who can I talk to with questions about CEPROTIN therapy?

For technical or medical questions about CEPROTIN therapy, contact your physician or call 1-888-CEPROTIN (1-888-237-7684) from 7 AM - 6 PM Central Standard Time, Monday through Friday.

Please see Important Risk Information and Full Prescribing Information for CEPROTIN.

You will need the free Adobe Reader to view PDF ( ) files on this page.
Get Adobe Reader.